<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Cefalexin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:27 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Cefalexin_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Cefalexin_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Cefalexin_files/filelist.xml">
<title>CEFALEXIN</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>lylv</o:LastAuthor>
  <o:Revision>5</o:Revision>
  <o:TotalTime>2</o:TotalTime>
  <o:Created>2006-08-08T14:03:00Z</o:Created>
  <o:LastSaved>2006-08-09T05:20:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>1602</o:Words>
  <o:Characters>9134</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>76</o:Lines>
  <o:Paragraphs>21</o:Paragraphs>
  <o:CharactersWithSpaces>10715</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>CEFALEXIN<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%;mso-outline-level:
1'><b><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Tên chung qu&#7889;c t&#7871;:</span></b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'> Cefalexin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%;mso-outline-level:
1'><b><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Mã ATC:</span></b><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> J01D A01.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.3pt'>Lo&#7841;i thu&#7889;c:</span></b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.3pt'> Thu&#7889;c kháng sinh u&#7889;ng, nhóm
cephalosporin th&#7871; h&#7879; 1.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%;mso-outline-level:1'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng
thu&#7889;c và hàm l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thu&#7889;c u&#7889;ng cefalexin là d&#7841;ng ng&#7853;m m&#7897;t
phân t&#7917; n&#432;&#7899;c ho&#7863;c d&#7841;ng hydroclorid. Li&#7873;u
&#273;&#432;&#7907;c bi&#7875;u th&#7883; theo s&#7889; l&#432;&#7907;ng
t&#432;&#417;ng &#273;&#432;&#417;ng c&#7911;a cefalexin khan. Nang và viên nén
250 mg, 500 mg; viên nén 1 g. Nh&#361; d&#7883;ch 125 mg, 250 mg/5 ml (sau khi
pha thêm n&#432;&#7899;c cho ch&#7871; ph&#7849;m). Siro 250 mg, 500 mg/5 ml
(sau khi pha thêm n&#432;&#7899;c cho ch&#7871; ph&#7849;m). Thu&#7889;c gi&#7885;t
dùng cho tr&#7867; em 125 mg/1,25 ml (sau khi pha thêm n&#432;&#7899;c cho ch&#7871;
ph&#7849;m).<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%;mso-outline-level:1'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
lý và c&#417; ch&#7871; tác d&#7909;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Cefalexin là kháng sinh nhóm cephalosporin th&#7871;
h&#7879; 1, có tác d&#7909;ng di&#7879;t khu&#7849;n b&#7857;ng cách &#7913;c
ch&#7871; t&#7893;ng h&#7907;p v&#7887; t&#7871; bào vi khu&#7849;n. Cefalexin
là kháng sinh u&#7889;ng, có ph&#7893; kháng khu&#7849;n nh&#432; các
cephalosporin th&#7871; h&#7879; 1. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefalexin b&#7873;n v&#7919;ng v&#7899;i penicilinase c&#7911;a <i>Staphylococcus</i>,
do &#273;ó có tác d&#7909;ng v&#7899;i c&#7843; các ch&#7911;ng <i>Staphylococcus</i>
<i>aureus</i> ti&#7871;t penicilinase kháng penicilin (hay ampicillin).
Cefalexin có tác d&#7909;ng in vitro trên các vi khu&#7849;n sau: <i>Streptococcus</i>
beta tan máu; <i>Staphylococcus</i>, g&#7891;m các ch&#7911;ng ti&#7871;t
coagulase (+), coagulase (-) và penicilinase; <i>Streptococcus pneumoniae</i>;
m&#7897;t s&#7889; <i>Escherichia coli; Proteus mirabilis</i>; m&#7897;t s&#7889;
<i><span style='letter-spacing:-.1pt'>Klebsiella </span></i><span
style='letter-spacing:-.1pt'>spp.<i> Branhamella catarrhalis; Shigella.
Haemophilus influenzae</i></span> th&#432;&#7901;ng gi&#7843;m nh&#7841;y c&#7843;m.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefalexin c&#361;ng có tác d&#7909;ng trên &#273;a s&#7889; các <i>E.
coli</i> kháng ampicillin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>H&#7847;u h&#7871;t các ch&#7911;ng <i>Enterococcus</i> <i>(Streptococcus
faecalis)</i> và m&#7897;t ít ch&#7911;ng Staphylococcus kháng cefalexin. <i>Proteus</i>
<i>indol </i>d&#432;&#417;ng tính, m&#7897;t s&#7889; <i>Enterobacter</i> spp, <i>Pseudomonas
aeruginosa, Bacteroides</i> spp, c&#361;ng th&#7845;y có kháng thu&#7889;c. Khi
th&#7917; nghi&#7879;m in vitro, <i>Staphylococcus</i> bi&#7875;u l&#7897; kh&#7843;
n&#259;ng kháng chéo gi&#7919;a cefalexin và các kháng sinh lo&#7841;i
methicilin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Theo s&#7889;
li&#7879;u (ASTS) 1997, cefalexin có tác d&#7909;ng v&#7899;i <i>Staphylococcus
aureus, Salmonella, E. coli</i> có t&#7881; l&#7879; kháng cefalexin kho&#7843;ng
50%; <i>Proteus </i>có t&#7881; l&#7879; kháng kho&#7843;ng 25%; <i>Enterobacter</i>
có t&#7881; l&#7879; kháng kho&#7843;ng 23%; <i>Pseudomonas aeruginosa</i> có t&#7881;
l&#7879; kháng kho&#7843;ng 20%.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%;mso-outline-level:
1'><i><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>D&#432;&#7907;c &#273;&#7897;ng h&#7885;c<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefalexin h&#7847;u nh&#432; &#273;&#432;&#7907;c h&#7845;p thu hoàn
toàn &#7903; &#273;&#432;&#7901;ng tiêu hóa và &#273;&#7841;t n&#7891;ng &#273;&#7897;
&#273;&#7881;nh trong huy&#7871;t t&#432;&#417;ng vào kho&#7843;ng 9 và 18
microgam/ml sau m&#7897;t gi&#7901; v&#7899;i li&#7873;u u&#7889;ng
t&#432;&#417;ng &#7913;ng 250 và 500 mg; li&#7873;u g&#7845;p &#273;ôi &#273;&#7841;t
n&#7891;ng &#273;&#7897; &#273;&#7881;nh g&#7845;p &#273;ôi. U&#7889;ng
cefalexin cùng v&#7899;i th&#7913;c &#259;n có th&#7875; làm ch&#7853;m kh&#7843;
n&#259;ng h&#7845;p thu nh&#432;ng t&#7893;ng l&#432;&#7907;ng thu&#7889;c h&#7845;p
thu không thay &#273;&#7893;i. Có t&#7899;i 15% li&#7873;u cefalexin g&#7855;n
k&#7871;t v&#7899;i protein huy&#7871;t t&#432;&#417;ng. N&#7917;a &#273;&#7901;i
trong huy&#7871;t t&#432;&#417;ng &#7903; ng&#432;&#7901;i l&#7899;n có ch&#7913;c
n&#259;ng th&#7853;n bình th&#432;&#7901;ng là 0,5 - 1,2 gi&#7901;, nh&#432;ng &#7903;
tr&#7867; s&#417; sinh dài h&#417;n (5 gi&#7901;); và t&#259;ng khi ch&#7913;c
n&#259;ng th&#7853;n suy gi&#7843;m. Cefalexin phân b&#7889; r&#7897;ng kh&#7855;p
c&#417; th&#7875;, nh&#432;ng l&#432;&#7907;ng trong d&#7883;ch não t&#7911;y
không &#273;áng k&#7875;. Cefalexin qua &#273;&#432;&#7907;c nhau thai và bài
ti&#7871;t vào s&#7919;a m&#7865; v&#7899;i n&#7891;ng &#273;&#7897; th&#7845;p.
Cefalexin không b&#7883; chuy&#7875;n hóa. Th&#7875; tích phân b&#7889; c&#7911;a
cefalexin là 18 lít/1,78 m<sup>2</sup> di&#7879;n tích c&#417; th&#7875;. Kho&#7843;ng
80% li&#7873;u dùng th&#7843;i tr&#7915; ra n&#432;&#7899;c ti&#7875;u &#7903;
d&#7841;ng không &#273;&#7893;i trong 6 gi&#7901; &#273;&#7847;u qua l&#7885;c
c&#7847;u th&#7853;n và bài ti&#7871;t &#7903; &#7889;ng th&#7853;n; v&#7899;i
li&#7873;u 500 mg cefalexin, n&#7891;ng &#273;&#7897; trong n&#432;&#7899;c ti&#7875;u
cao h&#417;n 1 mg/ml. Probenecid làm ch&#7853;m bài ti&#7871;t cefalexin trong
n&#432;&#7899;c ti&#7875;u. Có th&#7875; tìm th&#7845;y cefalexin &#7903; n&#7891;ng
&#273;&#7897; có tác d&#7909;ng tr&#7883; li&#7879;u trong m&#7853;t và m&#7897;t
ít cefalexin có th&#7875; th&#7843;i tr&#7915; qua &#273;&#432;&#7901;ng này.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefalexin &#273;&#432;&#7907;c &#273;ào th&#7843;i qua l&#7885;c máu
và th&#7849;m phân màng b&#7909;ng (20% - 50%).<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%;mso-outline-level:1'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881;
&#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefalexin &#273;&#432;&#7907;c ch&#7881; &#273;&#7883;nh trong &#273;i&#7873;u
tr&#7883; các nhi&#7877;m khu&#7849;n do các vi khu&#7849;n nh&#7841;y c&#7843;m,
nh&#432;ng không ch&#7881; &#273;&#7883;nh &#273;i&#7873;u tr&#7883; các nhi&#7877;m
khu&#7849;n n&#7863;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Nhi&#7877;m khu&#7849;n &#273;&#432;&#7901;ng hô h&#7845;p: Viêm ph&#7871;
qu&#7843;n c&#7845;p và m&#7841;n tính và giãn ph&#7871; qu&#7843;n nhi&#7877;m
khu&#7849;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Nhi&#7877;m khu&#7849;n tai, m&#361;i, h&#7885;ng: Viêm tai gi&#7919;a,
viêm x&#432;&#417;ng ch&#361;m, viêm xoang, viêm ami&#273;an h&#7889;c và viêm
h&#7885;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Viêm &#273;&#432;&#7901;ng ti&#7871;t ni&#7879;u: Viêm bàng quang và
viêm tuy&#7871;n ti&#7873;n li&#7879;t. Ði&#7873;u tr&#7883; d&#7921; phòng nhi&#7877;m
khu&#7849;n &#273;&#432;&#7901;ng ni&#7879;u tái phát. <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Nhi&#7877;m khu&#7849;n s&#7843;n và ph&#7909; khoa.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Nhi&#7877;m khu&#7849;n da, mô m&#7873;m và x&#432;&#417;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>B&#7879;nh l&#7853;u (khi penicilin không phù h&#7907;p).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Nhi&#7877;m khu&#7849;n r&#259;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ði&#7873;u tr&#7883; d&#7921; phòng thay penicilin cho ng&#432;&#7901;i
b&#7879;nh m&#7855;c b&#7879;nh tim ph&#7843;i &#273;i&#7873;u tr&#7883;
r&#259;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ghi chú: Nên ti&#7871;n hành nuôi c&#7845;y và th&#7917; nghi&#7879;m
tính nh&#7841;y c&#7843;m c&#7911;a vi khu&#7849;n tr&#432;&#7899;c và trong
khi &#273;i&#7873;u tr&#7883;. C&#7847;n &#273;ánh giá ch&#7913;c n&#259;ng th&#7853;n
khi có ch&#7881; &#273;&#7883;nh.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%;mso-outline-level:1'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng
ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefalexin không dùng cho ng&#432;&#7901;i b&#7879;nh có ti&#7873;n s&#7917;
d&#7883; &#7913;ng v&#7899;i kháng sinh nhóm cephalosporin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Không dùng cephalosporin cho ng&#432;&#7901;i b&#7879;nh có ti&#7873;n
s&#7917; s&#7889;c ph&#7843;n v&#7879; do penicilin ho&#7863;c ph&#7843;n &#7913;ng
tr&#7847;m tr&#7885;ng khác qua trung gian globulin mi&#7877;n d&#7883;ch IgE.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%;mso-outline-level:1'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n
tr&#7885;ng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefalexin th&#432;&#7901;ng &#273;&#432;&#7907;c dung n&#7841;p t&#7889;t
ngay c&#7843; &#7903; ng&#432;&#7901;i b&#7879;nh d&#7883; &#7913;ng v&#7899;i
penicilin, tuy nhiên c&#361;ng có m&#7897;t s&#7889; r&#7845;t ít b&#7883; d&#7883;
&#7913;ng chéo.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Gi&#7889;ng nh&#432; nh&#7919;ng kháng sinh ph&#7893; r&#7897;ng khác,
s&#7917; d&#7909;ng cefalexin dài ngày có th&#7875; làm phát tri&#7875;n quá m&#7913;c
các vi khu&#7849;n không nh&#7841;y c&#7843;m (ví d&#7909;, <i>Candida,
Enterococcus, Clostridium difficile),</i> trong tr&#432;&#7901;ng h&#7907;p này
nên ng&#7915;ng thu&#7889;c. Ðã có thông báo viêm &#273;&#7841;i tràng màng gi&#7843;
khi s&#7917; d&#7909;ng các kháng sinh ph&#7893; r&#7897;ng, vì v&#7853;y c&#7847;n
ph&#7843;i chú ý t&#7899;i vi&#7879;c ch&#7849;n &#273;oán b&#7879;nh này &#7903;
ng&#432;&#7901;i b&#7879;nh tiêu ch&#7843;y n&#7863;ng trong ho&#7863;c sau khi
dùng kháng sinh.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Gi&#7889;ng nh&#432; v&#7899;i nh&#7919;ng kháng sinh &#273;&#432;&#7907;c
&#273;ào th&#7843;i ch&#7911; y&#7871;u qua th&#7853;n, khi th&#7853;n suy, ph&#7843;i
gi&#7843;m li&#7873;u cefalexin cho thích h&#7907;p. Th&#7921;c nghi&#7879;m
trên labo và kinh nghi&#7879;m lâm sàng không có b&#7857;ng ch&#7913;ng gây
quái thai, tuy nhiên nên th&#7853;n tr&#7885;ng khi dùng trong nh&#7919;ng
tháng &#273;&#7847;u c&#7911;a thai kì nh&#432; &#273;&#7889;i v&#7899;i m&#7885;i
lo&#7841;i thu&#7889;c khác.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:.1pt'>&#7902; ng&#432;&#7901;i b&#7879;nh dùng cefalexin
có th&#7875; có ph&#7843;n &#7913;ng d&#432;&#417;ng tính gi&#7843; khi xét
nghi&#7879;m glucose ni&#7879;u b&#7857;ng dung d&#7883;ch
&quot;Benedict&quot;, dung d&#7883;ch &quot;Fehling&quot; hay viên
&quot;Clinitest&quot;, nh&#432;ng v&#7899;i các xét nghi&#7879;m b&#7857;ng
enzym thì không b&#7883; &#7843;nh h&#432;&#7903;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Có thông báo cefalexin gây d&#432;&#417;ng tính th&#7917; nghi&#7879;m
Coombs.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Cefalexin có th&#7875; &#7843;nh h&#432;&#7903;ng &#273;&#7871;n vi&#7879;c
&#273;&#7883;nh l&#432;&#7907;ng creatinin b&#7857;ng picrat ki&#7873;m, cho k&#7871;t
qu&#7843; cao gi&#7843; t&#7841;o, tuy nhiên m&#7913;c t&#259;ng d&#432;&#7901;ng
nh&#432; không có ý ngh&#297;a trong lâm sàng. <o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%;mso-outline-level:1'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; mang thai <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Nghiên c&#7913;u th&#7921;c nghi&#7879;m và kinh nghi&#7879;m lâm sàng
ch&#432;a cho th&#7845;y có d&#7845;u hi&#7879;u v&#7873; &#273;&#7897;c tính
cho thai và gây quái thai. Tuy nhiên ch&#7881; nên dùng cefalexin cho ng&#432;&#7901;i
mang thai khi th&#7853;t c&#7847;n.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%;mso-outline-level:1'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; cho con bú<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>N&#7891;ng &#273;&#7897; cefalexin trong s&#7919;a m&#7865; r&#7845;t
th&#7845;p. M&#7863;c d&#7847;u v&#7853;y, v&#7851;n nên cân nh&#7855;c vi&#7879;c
ng&#7915;ng cho con bú nh&#7845;t th&#7901;i trong th&#7901;i gian mà ng&#432;&#7901;i
m&#7865; dùng cefalexin.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%;mso-outline-level:1'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tác d&#7909;ng
không mong mu&#7889;n (ADR)<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>T&#7881; l&#7879; ph&#7843;n &#7913;ng không mong mu&#7889;n kho&#7843;ng
3 - 6% trên toàn b&#7897; s&#7889; ng&#432;&#7901;i b&#7879;nh &#273;i&#7873;u
tr&#7883;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#432;&#7901;ng g&#7863;p, ADR &gt;1/100<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêu hóa: Tiêu ch&#7843;y, bu&#7891;n nôn.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ít g&#7863;p, 1/1000 &lt; ADR &lt; 1/100<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Máu: T&#259;ng b&#7841;ch c&#7847;u &#432;a eosin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Da: N&#7893;i ban, mày &#273;ay, ng&#7913;a.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Gan: T&#259;ng transaminase gan có h&#7891;i ph&#7909;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Hi&#7871;m g&#7863;p, ADR &lt;1/1000<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Toàn thân: Ðau &#273;&#7847;u, chóng m&#7863;t, ph&#7843;n &#7913;ng
ph&#7843;n v&#7879;, m&#7879;t m&#7887;i.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Máu: Gi&#7843;m b&#7841;ch c&#7847;u trung tính, gi&#7843;m ti&#7875;u
c&#7847;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêu hóa: R&#7889;i lo&#7841;n tiêu hóa, &#273;au b&#7909;ng, viêm
&#273;&#7841;i tràng gi&#7843; m&#7841;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Da: H&#7897;i ch&#7913;ng Stevens - Johnson, h&#7891;ng ban &#273;a d&#7841;ng,
ho&#7841;i t&#7917; bi&#7875;u bì nhi&#7877;m &#273;&#7897;c (h&#7897;i ch&#7913;ng
Lyell), phù Quincke.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Gan: Viêm gan, vàng da &#7913; m&#7853;t.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Ti&#7871;t ni&#7879;u - sinh d&#7909;c: Ng&#7913;a
b&#7897; ph&#7853;n sinh d&#7909;c, viêm âm &#273;&#7841;o, viêm th&#7853;n k&#7869;
có h&#7891;i ph&#7909;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Ðã có thông báo v&#7873; nh&#7919;ng tri&#7879;u
ch&#7913;ng th&#7847;n kinh trung &#432;&#417;ng nh&#432; chóng m&#7863;t, l&#7851;n,
kích &#273;&#7897;ng và &#7843;o giác, nh&#432;ng ch&#432;a hoàn toàn ch&#7913;ng
minh &#273;&#432;&#7907;c m&#7889;i liên quan v&#7899;i cefalexin.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>H&#432;&#7899;ng d&#7851;n cách x&#7917; trí ADR<span
style='color:white'><o:p></o:p></span></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Ng&#7915;ng cefalexin. N&#7871;u d&#7883; &#7913;ng
ho&#7863;c quá m&#7851;n nghiêm tr&#7885;ng, c&#7847;n ti&#7871;n hành &#273;i&#7873;u
tr&#7883; h&#7895; tr&#7907; (&#273;&#7843;m b&#7843;o thông khí và s&#7917; d&#7909;ng
epinephrin, oxygen, tiêm steroid t&#297;nh m&#7841;ch).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>N&#7871;u viêm &#273;&#7841;i tràng có màng gi&#7843;
th&#7875; nh&#7865; th&#432;&#7901;ng ch&#7881; c&#7847;n ng&#7915;ng thu&#7889;c,
các tr&#432;&#7901;ng h&#7907;p th&#7875; v&#7915;a và n&#7863;ng, c&#7847;n
l&#432;u ý cho dùng các d&#7883;ch và ch&#7845;t &#273;i&#7879;n gi&#7843;i, b&#7893;
sung protein và &#273;i&#7873;u tr&#7883; kháng sinh có tác d&#7909;ng &#273;i&#7873;u
tr&#7883; viêm &#273;&#7841;i tràng do <i>C. difficile</i>.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%;mso-outline-level:1'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Li&#7873;u l&#432;&#7907;ng và cách dùng<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Cefalexin dùng theo &#273;&#432;&#7901;ng u&#7889;ng.
Li&#7873;u th&#432;&#7901;ng dùng cho ng&#432;&#7901;i l&#7899;n, u&#7889;ng
250 - 500 mg cách 6 gi&#7901;/1 l&#7847;n, tùy theo m&#7913;c &#273;&#7897; nhi&#7877;m
khu&#7849;n. Li&#7873;u có th&#7875; lên t&#7899;i 4 g/ngày. Nh&#432;ng khi c&#7847;n
li&#7873;u cao h&#417;n, c&#7847;n cân nh&#7855;c dùng m&#7897;t cephalosporin
tiêm.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Tr&#7867; em: Li&#7873;u th&#432;&#7901;ng dùng
là 25 - 60 mg/kg th&#7875; tr&#7885;ng trong 24 gi&#7901;, chia thành 2 - 3 l&#7847;n
u&#7889;ng. Tr&#432;&#7901;ng h&#7907;p nhi&#7877;m khu&#7849;n n&#7863;ng, li&#7873;u
t&#7889;i &#273;a là 100 mg /kg th&#7875; tr&#7885;ng trong 24 gi&#7901;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>L&#432;u ý:</span></i><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'> Th&#7901;i gian &#273;i&#7873;u tr&#7883; nên
kéo dài ít nh&#7845;t t&#7915; 7 &#273;&#7871;n 10 ngày, nh&#432;ng trong các
nhi&#7877;m khu&#7849;n &#273;&#432;&#7901;ng ni&#7879;u ph&#7913;c t&#7841;p,
tái phát, m&#7841;n tính, nên &#273;i&#7873;u tr&#7883; 2 tu&#7847;n (1 g/l&#7847;n,
ngày u&#7889;ng 2 l&#7847;n). V&#7899;i b&#7879;nh l&#7853;u, th&#432;&#7901;ng
dùng li&#7873;u duy nh&#7845;t 3 g v&#7899;i 1 g probenecid cho nam hay 2 g v&#7899;i
0,5 g probenecid cho n&#7919;. Dùng k&#7871;t h&#7907;p v&#7899;i probenecid s&#7869;
kéo dài th&#7901;i gian &#273;ào th&#7843;i c&#7911;a cefalexin và làm
t&#259;ng n&#7891;ng &#273;&#7897; trong huy&#7871;t thanh t&#7915; 50 - 100%.
Cho &#273;&#7871;n nay, cefalexin ch&#432;a th&#7845;y có &#273;&#7897;c tính v&#7899;i
th&#7853;n. Tuy nhiên, c&#361;ng nh&#432; &#273;&#7889;i v&#7899;i nh&#7919;ng
kháng sinh &#273;ào th&#7843;i ch&#7911; y&#7871;u qua th&#7853;n, có th&#7875;
có tích t&#7909; thu&#7889;c trong c&#417; th&#7875; khi ch&#7913;c n&#259;ng
th&#7853;n gi&#7843;m d&#432;&#7899;i m&#7897;t n&#7917;a m&#7913;c bình
th&#432;&#7901;ng. Do &#273;ó, nên gi&#7843;m li&#7873;u t&#7889;i &#273;a khuy&#7871;n
cáo (ngh&#297;a là 6 g/ngày cho ng&#432;&#7901;i l&#7899;n, 4 g/ngày cho tr&#7867;
em) cho phù h&#7907;p v&#7899;i nh&#7919;ng b&#7879;nh này. &#7902; ng&#432;&#7901;i
cao tu&#7893;i, c&#7847;n &#273;ánh giá m&#7913;c &#273;&#7897; suy th&#7853;n.
<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Ð<span style='letter-spacing:-.1pt'>i&#7873;u ch&#7881;nh
li&#7873;u khi có suy th&#7853;n: N&#7871;u &#273;&#7897; thanh th&#7843;i
creatinin (TTC) </span></span><span lang=DE style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Symbol;mso-ascii-font-family:Verdana;
mso-hansi-font-family:Verdana;letter-spacing:-.1pt;mso-ansi-language:DE;
mso-char-type:symbol;mso-symbol-font-family:Symbol'><span style='mso-char-type:
symbol;mso-symbol-font-family:Symbol'>³</span></span><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt;mso-ansi-language:DE'> 50 ml/phút, creatinin huy&#7871;t
thanh (CHT) </span><span lang=DE style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Symbol;mso-ascii-font-family:Verdana;
mso-hansi-font-family:Verdana;letter-spacing:-.1pt;mso-ansi-language:DE;
mso-char-type:symbol;mso-symbol-font-family:Symbol'><span style='mso-char-type:
symbol;mso-symbol-font-family:Symbol'>£</span></span><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt;mso-ansi-language:DE'> 132 micromol/l, li&#7873;u
duy trì t&#7889;i &#273;a (LDTTÐ) 1 g, 4l&#7847;n trong 24 gi&#7901;. N&#7871;u
TTC là 49 - 20 ml/phút, CHT: 133 - 295 micromol/lít, LDTTÐ: 1 g, 3 l&#7847;n
trong 24 gi&#7901;; n&#7871;u TTC là 19 - 10 ml/phút, CHT: 296 - 470
micromol/lít, LDTTÐ: 500 mg, 3 l&#7847;n trong 24 gi&#7901;; n&#7871;u TTC </span><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Symbol;mso-ascii-font-family:Verdana;mso-hansi-font-family:Verdana;
letter-spacing:-.1pt;mso-ansi-language:DE;mso-char-type:symbol;mso-symbol-font-family:
Symbol'><span style='mso-char-type:symbol;mso-symbol-font-family:Symbol'>£</span></span><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;letter-spacing:-.1pt;mso-ansi-language:DE'> 10 ml/phút, CHT
</span><span lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Symbol;mso-ascii-font-family:Verdana;mso-hansi-font-family:
Verdana;letter-spacing:-.1pt;mso-ansi-language:DE;mso-char-type:symbol;
mso-symbol-font-family:Symbol'><span style='mso-char-type:symbol;mso-symbol-font-family:
Symbol'>³</span></span><span lang=DE style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana;letter-spacing:-.1pt;mso-ansi-language:
DE'> 471 micromol/lít, LDTTÐ: 250 mg, 2 l&#7847;n trong 24 gi&#7901;.</span><span
lang=DE style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'><o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%;mso-outline-level:1'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Dùng cephalosporin li&#7873;u cao cùng v&#7899;i
các thu&#7889;c khác c&#361;ng &#273;&#7897;c v&#7899;i th&#7853;n, nh&#432;
aminoglycosid hay thu&#7889;c l&#7907;i ti&#7875;u m&#7841;nh (ví d&#7909;
furosemid, acid ethacrynic và piretanid) có th&#7875; &#7843;nh h&#432;&#7903;ng
x&#7845;u t&#7899;i ch&#7913;c n&#259;ng th&#7853;n. Kinh nghi&#7879;m lâm sàng
cho th&#7845;y không có v&#7845;n &#273;&#7873; gì v&#7899;i cefalexin &#7903;
m&#7913;c li&#7873;u &#273;ã khuy&#7871;n cáo.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Ðã có nh&#7919;ng thông báo l&#7867; t&#7867; v&#7873;
cefalexin làm gi&#7843;m tác d&#7909;ng c&#7911;a oestrogen trong thu&#7889;c u&#7889;ng
tránh th&#7909; thai.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Cholestyramin g&#7855;n v&#7899;i cefalexin &#7903;
ru&#7897;t làm ch&#7853;m s&#7921; h&#7845;p thu c&#7911;a chúng.
T&#432;&#417;ng tác này có th&#7875; ít quan tr&#7885;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Probenecid làm t&#259;ng n&#7891;ng &#273;&#7897;
trong huy&#7871;t thanh và t&#259;ng th&#7901;i gian bán th&#7843;i c&#7911;a
cefalexin. Tuy nhiên, th&#432;&#7901;ng không c&#7847;n ph&#7843;i quan tâm gì
&#273;&#7863;c bi&#7879;t. T&#432;&#417;ng tác này &#273;ã &#273;&#432;&#7907;c
khai thác &#273;&#7875; &#273;i&#7873;u tr&#7883; b&#7879;nh l&#7853;u (xin
&#273;&#7885;c ph&#7847;n &quot;li&#7873;u l&#432;&#7907;ng&quot;).<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%;mso-outline-level:1'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ð&#7897; &#7893;n &#273;&#7883;nh và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Nên gi&#7919; viên và nang cefalexin trong l&#7885;
kín, b&#7843;o qu&#7843;n &#7903; nhi&#7879;t &#273;&#7897; 15 - 30<sup>o</sup>C
và tránh ánh sáng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Siro và d&#7883;ch treo &#273;ã pha n&#432;&#7899;c
v&#7851;n gi&#7919; &#273;&#432;&#7907;c hi&#7879;u l&#7921;c trong 10 ngày n&#7871;u
b&#7843;o qu&#7843;n &#7903; n&#417;i mát, trong t&#7911; l&#7841;nh thì t&#7889;t
h&#417;n. Siro &#273;ã pha, có th&#7875; pha loãng v&#7899;i n&#432;&#7899;c,
sau &#273;ó ch&#7881; nên dùng trong vòng 7 ngày.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%;mso-outline-level:1'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Quá li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Sau quá li&#7873;u c&#7845;p tính, ph&#7847;n l&#7899;n
ch&#7881; gây bu&#7891;n nôn, nôn và tiêu ch&#7843;y, tuy nhiên có th&#7875;
gây quá m&#7851;n th&#7847;n kinh c&#417; và c&#417;n &#273;&#7897;ng kinh,
&#273;&#7863;c bi&#7879;t &#7903; ng&#432;&#7901;i b&#7879;nh b&#7883; suy th&#7853;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>X&#7917; trí quá li&#7873;u c&#7847;n xem xét
&#273;&#7871;n kh&#7843; n&#259;ng quá li&#7873;u c&#7911;a nhi&#7873;u lo&#7841;i
thu&#7889;c, s&#7921; t&#432;&#417;ng tác thu&#7889;c và d&#432;&#7907;c &#273;&#7897;ng
h&#7885;c b&#7845;t th&#432;&#7901;ng c&#7911;a ng&#432;&#7901;i b&#7879;nh.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Không c&#7847;n ph&#7843;i r&#7917;a d&#7841;
dày, tr&#7915; khi &#273;ã u&#7889;ng cefalexin g&#7845;p 5 - 10 l&#7847;n li&#7873;u
bình th&#432;&#7901;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>L&#7885;c máu có th&#7875; giúp &#273;ào th&#7843;i
thu&#7889;c kh&#7887;i máu, nh&#432;ng th&#432;&#7901;ng không c&#7847;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>B&#7843;o v&#7879; &#273;&#432;&#7901;ng hô h&#7845;p
c&#7911;a ng&#432;&#7901;i b&#7879;nh, h&#7895; tr&#7907; thông khí và truy&#7873;n
d&#7883;ch. Cho u&#7889;ng than ho&#7841;t nhi&#7873;u l&#7847;n thay th&#7871;
ho&#7863;c thêm vào vi&#7879;c r&#7917;a d&#7841; dày. C&#7847;n b&#7843;o v&#7879;
&#273;&#432;&#7901;ng hô h&#7845;p c&#7911;a ng&#432;&#7901;i b&#7879;nh lúc
&#273;ang r&#7917;a d&#7841; dày ho&#7863;c &#273;ang dùng than ho&#7841;t<i>.<o:p></o:p></i></span></p>

<p class=cach0 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Thông tin qui ch&#7871;<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>Cefalexin có trong danh m&#7909;c thu&#7889;c thi&#7871;t
y&#7871;u Vi&#7879;t Nam ban hành l&#7847;n th&#7913; t&#432; n&#259;m 1999.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Thu&#7889;c ph&#7843;i kê &#273;&#417;n và bán thu&#7889;c
theo &#273;&#417;n.</span><span style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana'><o:p></o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Cefalexin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:27 GMT -->
</html>
